Geoffrey Biegler

Full contact info


Cooley Wins at the PTAB for NeuroDerm

November 1, 2023

Cooley is representing NeuroDerm and its parent company, Mitsubishi Tanabe Pharma Corp., in a post-grant review challenging an AbbVie patent related to methods of continuous subcutaneous treatment of Parkinson’s disease. After a hearing in October 2023, the US Patent Trial and Appeal Board issued a final written decision finding all claims of AbbVie’s patent unpatentable.

NeuroDerm and AbbVie are both seeking regulatory approval in the US for continuous subcutaneous treatments for Parkinson’s disease, and AbbVie’s patent effectively attempted to claim all successful methods of such treatment. Lawyers Geoff Biegler and Mark Weinstein are leading the team representing NeuroDerm with assistance from associates, Bonnie Fletcher Price and Andrew Lau.

Related contacts

Geoffrey Biegler
Partner, San Diego
Mark Weinstein
Partner, Palo Alto
Bonnie Fletcher Price
Associate, Washington, DC
Andrew Lau
Associate, Palo Alto

Related Practices & Industries

Admissions and credentials


Rankings and accolades

Best Lawyers: Top IP Lawyer

Super Lawyers: Rising Star

Memberships and affiliations

American Intellectual Property Law Association

Federal Circuit Bar Association

Federal Bar Association